Cardinal Health, Inc.
CAH
NYSE·Healthcare·Medical - Distribution·Mkt cap $57.9B
$247.18
▼ -0.58%
P/E
34.09
Mkt Cap
$57.9B
52-Wk Range
$145.87–$258.30
52-Week Range
$145.87 - $258.30
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 64.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Extensive Healthcare Provider Network
- Comprehensive Supply Chain Infrastructure
- Diversified Service Portfolio
- Strong Manufacturer Relationships
Bear Case
1 risk
- Low volatility (beta 0.5).
Growth
Stable outlook
Healthcare Technology Integration
Value
Fairly valued vs Healthcare Distribution peers
Momentum
Hot
+20.9% over 3m
Quality
Thin
Excellent business quality
Dividend
Modest
0.83% yield
Smart-money signal
Who's buying CAH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
AUG 11, 2026
Reported EPS of $2.91 vs $2.42 consensus (+20.3% surprise). Revenue of $63.7B vs $65.2B expected (-2.3%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+20.3%
Revenue trend · last 8Q
—
-4%
+0%
+1%
+22%
+18%
+11%
+6%
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q3 26
Q4 26
$52.3B
$55.3B
$54.9B
$60.2B
$64.0B
$65.4B
$60.9B
$63.9B
Margins · last 8Q
Gross
4.3%
Operating
1.1%
Profit
0.6%
Wall Street consensus
8 analysts · 88% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
88%
Hold
13%
Sell
0%
Median Price Target
—
Latest: Barclays · Aug 13, 2026
vs Industry
How CAH stacks vs Medical - Distribution
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related